Randomized, Blinded Trial of Vitamin D(3) for Treating Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS)

PURPOSE: To evaluate the efficacy and safety of vitamin D(3) at 4,000 IU/day as a treatment option for aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) when compared with the usual care dose of 600 IU D(3). METHODS: Single site randomized, double-blind, phase 3 clinical trial in women...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Breast Cancer Res Treat
Hoofdauteurs: Shapiro, Alice C., Adlis, Susan A., Robien, Kim, Kirstein, Mark N., Liang, Shuang, Richter, Sara A., Lerner, Rachel E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5260816/
https://ncbi.nlm.nih.gov/pubmed/26868123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3710-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items